These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25547358)

  • 1. Clavanin A improves outcome of complications from different bacterial infections.
    Silva ON; Fensterseifer IC; Rodrigues EA; Holanda HH; Novaes NR; Cunha JP; Rezende TM; Magalhães KG; Moreno SE; Jerônimo MS; Bocca AL; Franco OL
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1620-6. PubMed ID: 25547358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clavanin bacterial sepsis control using a novel methacrylate nanocarrier.
    Saúde AC; Ombredane AS; Silva ON; Barbosa JA; Moreno SE; Araujo AC; Falcão R; Silva LP; Dias SC; Franco OL
    Int J Nanomedicine; 2014; 9():5055-69. PubMed ID: 25382976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pH and salinity on the antimicrobial properties of clavanins.
    Lee IH; Cho Y; Lehrer RI
    Infect Immun; 1997 Jul; 65(7):2898-903. PubMed ID: 9199465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clavanin A-bioconjugated Fe
    Ribeiro KL; Frías IAM; Franco OL; Dias SC; Sousa-Junior AA; Silva ON; Bakuzis AF; Oliveira MDL; Andrade CAS
    Colloids Surf B Biointerfaces; 2018 Sep; 169():72-81. PubMed ID: 29751343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of the Innate Immune System of Styela clava: Zn
    Juliano SA; Pierce S; deMayo JA; Balunas MJ; Angeles-Boza AM
    Biochemistry; 2017 Mar; 56(10):1403-1414. PubMed ID: 28226206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of lysozyme with oleoyl chloride for broadening the antimicrobial specificity.
    Evran S; Yasa I; Telefoncu A
    Prep Biochem Biotechnol; 2010; 40(4):316-25. PubMed ID: 21108135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria.
    Domingues MM; Silva PM; Franquelim HG; Carvalho FA; Castanho MA; Santos NC
    Nanomedicine; 2014 Apr; 10(3):543-51. PubMed ID: 24262996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Activity of Truncated and Polyvalent Peptides Derived from the FKCRRQWQWRMKKGLA Sequence against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923.
    Huertas NJ; Monroy ZJR; Medina RF; Castañeda JEG
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28613262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities.
    Silva ON; de la Fuente-Núñez C; Haney EF; Fensterseifer IC; Ribeiro SM; Porto WF; Brown P; Faria-Junior C; Rezende TM; Moreno SE; Lu TK; Hancock RE; Franco OL
    Sci Rep; 2016 Nov; 6():35465. PubMed ID: 27804992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective control of Salmonella infections by employing combinations of recombinant antimicrobial human β-defensins hBD-1 and hBD-2.
    Maiti S; Patro S; Purohit S; Jain S; Senapati S; Dey N
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6896-903. PubMed ID: 25199778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Potent Host Defense Peptide Triggers DNA Damage and Is Active against Multidrug-Resistant Gram-Negative Pathogens.
    Juliano SA; Serafim LF; Duay SS; Heredia Chavez M; Sharma G; Rooney M; Comert F; Pierce S; Radulescu A; Cotten ML; Mihailescu M; May ER; Greenwood AI; Prabhakar R; Angeles-Boza AM
    ACS Infect Dis; 2020 May; 6(5):1250-1263. PubMed ID: 32251582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.
    Brouwer CP; Bogaards SJ; Wulferink M; Velders MP; Welling MM
    Peptides; 2006 Nov; 27(11):2585-91. PubMed ID: 16814900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.
    Lee IH; Zhao C; Cho Y; Harwig SS; Cooper EL; Lehrer RI
    FEBS Lett; 1997 Jan; 400(2):158-62. PubMed ID: 9001389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.
    Zhang Q; Xu Y; Wang Q; Hang B; Sun Y; Wei X; Hu J
    Antimicrob Agents Chemother; 2015 May; 59(5):2835-41. PubMed ID: 25753638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
    Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
    Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
    Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
    J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimicrobial evaluation of 5-aryl-1,2,4-triazole-3-thione derivatives containing a rhodanine moiety.
    Li C; Liu JC; Li YR; Gou C; Zhang ML; Liu HY; Li XZ; Zheng CJ; Piao HR
    Bioorg Med Chem Lett; 2015 Aug; 25(15):3052-6. PubMed ID: 26048807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic mimics of antimicrobial peptides with immunomodulatory responses.
    Thaker HD; Som A; Ayaz F; Lui D; Pan W; Scott RW; Anguita J; Tew GN
    J Am Chem Soc; 2012 Jul; 134(27):11088-91. PubMed ID: 22697149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.
    Conlon JM; Abraham B; Galadari S; Knoop FC; Sonnevend A; Pál T
    Peptides; 2005 Nov; 26(11):2104-10. PubMed ID: 15885852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.